We conducted a retrospec tive study of 4,848 patients to evaluate the age-specific incidence ofpost-tonsillectomy hemorrhage that required surgica l treatment. We reviewed the charts of2,567 patients younger than 15 years (pediatric gro up) and 2,281 patients aged 15 years and older (adult gro up) who had undergone tonsillectomy with or without adenoidectomy. We fo und that posttonsillec tomy hemorrhage occurred significantly more often in the adult group (3.9 vs 1.6%; p<O.OOI). Moreover, primm}' hemorrhage «24 hr postoperatively) was also significantly more common in the adult group than in the pediatric group (82.9 vs 65.9 %, p = 0.023). Analysis ofotherparameters revealed that post-tonsillectomy hemorrhage was significantly more common in males and in patients who had a history of chronic or recurrent throat infection. Awareness of these risk fa ctors should help improve pati ent care and outcomes.
Introduction
Postsurgical hemorrhage, the majo r complication of tonsillectomy and a potenti ally life-th reatening occurrence , is classified as primary « 24 hr postoperatively) or seconda ry (>24 hr). In children youn ger than 3 years of age, surge ry is also complicated by dehydration, poor oral intake of fluid s and solids, and upper airway problem s, especia lly in cases where adenotonsillec tomy has been performed to resolve breath ing problem s.1·3 Primary hemorr hage is co nside red to be more ser ious than seco nda ry hemorrhage, but the experience in our clinic has been that seco ndary bleeding can also be brisk and -mas sive and require treatment under general anesthesia. Despite continuous spec ialization in otolaryngolo gy, surgeo ns in many departments opera te on patients of all ages . Many authors belie ve that age is asso ciated with the risk of postoperati ve hem orrhage. However, there is no widely acce pted intern ational definition of age ranges. The American Medi cal Association classifies people as neonates « I mo of age), inf ants ( I mo to 2 yr), children (2 to 13 yr), adolesce nts ( 13 to 17 yr), and adult s (~1 8 yr). On the other hand , many pedi atric societies use 15 years as the threshold for adulthood. Therefore , reports of surg ical results obtained only in "c hildren" are of limited value in educating clinicians. These studies would be more useful if resear chers co uld agree on a comm on cla ssification of age when reporting result s in populations that include a bro ad range of ages. Mor eover, a comm on class ification system would be bene ficial from a medicolegal perspective becau se physicians could provide patient s with more precise information regarding the risk of compli cation s.
In this article , we rep ort the results of our retro spective study of post-tonsill ect om y hemo rrh age , with or without ade noidectomy, in a large popul ation with a broad range of ages. For our study, we classified patient s youn ger than 15 years as children and patients 15 yea rs and older as adults.
Patients and methods
We reviewed the ch arts of 4,848 patient s who had undergo ne tonsillectomy, with or without ade noidectomy, at our clinic betwe en] an. 1, 1988, and Aug. 31, 2000. Indications for surgery included the managem ent of upper airway a bstruction, recurrent or chronic thro at infecti on, and recurrent childhood ear disease. Patient s who had risk fac tors for hemorrh age (e.g., hypertension, hyperthyroidism, and anticoagulation therapy ) were managed preoperatively; those who did not respond did not undergo surge ry. We compiled data on all patients in whom postoperative bleeding from the tonsillar fossae required treatment under general anesthesia to prevent cardiovascular collapse . We used the Pearson chi-squared test (p<0.05) to compare the bleeding rates in the two groups . We excluded from our analysis patients who had periton sillar abscess, malignant disease , or sleep apnea (confirmed by overnight monitoring). We also did not include patients who underwent adenoid ectomy without tonsillectomy as well as those who had previously undergone adenoidectomy or tonsillectomy. We divided patients into two groups based on age and designated them as the pediatric group and the adult group:
Pediatric group. The pediatric group was made up of 2,567 patients aged 6 month s to 14.9 years (mean: 7.3; median: 6; standard deviation [SD]:±3.72); 1,364 (53.1%) were boys (figure 1). Adenotonsillectomy was performed in 1,832 of these patients (7 1.4%) to treat upper airw ay obstruction caused by adenotonsillar hypertrophy; the remaining 735 patients (28.6%) underwent tonsillectomy alone for recurrent episodes of tonsillitis (more than five episodes per year or more than three episodes that required antibiotic treatment).
Adult group. The adult group was made up of 2,281 patients aged 15.0 to 93 years (mean: 31.5 ; median: 27; 628 SD: ± 14.4); 1,059 (46.4 %) were men (figure 1). Of this group , 2,105 (92.3%) underwent tonsillectomy alone for recurrent episodes of tonsillitis (same criteria) and 176 (7.7%) underwent adenotonsillectomy for upper airway obstruction caused by adenotonsillar hypertrophy.
All procedures were performed with genera l anesthe sia and oral intubation. The tonsils were removed via the dissection technique, and hemostasis was achieved by suture ligation ; cautery was not used. Adenoidectomy was performed via curett age with an adenotome, and hemostasis achieved by temporarily packing thenasopharynx with sponges soaked in epinephrine. Patients refrained from eating and drinking for 6 hours postoperatively. Prophylactic antibiotics were admini stered to prevent endocarditis. The surgeon made at least two round s per day in the ward, and the nursing staff provided continuous monitoring, which made early recognition of postoperative hemorrhage possible.
Patients in both group s who did not experience any complications were disch arged 6 days after surgery in accordance with nation al guidelines. (The length of posttonsillectomy hospital stay is a topic of debate in Germany.) Patients who did experience postoperative hemorrhage were sent home when their general condition, hemog lobin conce ntration, and state of wound healing allo wed for safe disch arge. Those patient s who had undergone ligat ion of the externa l carotid artery because of massive blood loss were discharged only after their wound s had completely healed. 6 5 2 spec tively (figure 3). Th e latest episode of bleedin g occurred in an adult on postoperative day 18.
Rates according to sex . In the pedi atric group, the rates of pos toperative bleedin g amo ng boys and girls were co mpara ble ( 1.5 and 1.7%, respectively; p =0.47 ). In the adult gro up, men had a sign ificantly higher rate than women (5.5 vs 2.5%; p <O.OOI ).
Rates according to time of onset. Of the 41 hem orrhages in the pedi atric group, 27 (65.9%) were prim ary. Prim ary hemorrh age s account ed for 73 of the 88 hemorrhages (82.9%) in the adult gro up. Th e difference in these rate s was statistically significant (p = 0.023 ).
Severe complications. Am ong the total popu lation of 4,84 8 patients, only seven (0.14% ) experienced severe co mplications that required a blood transfu sion or ligation of the external carotid artery-one in the pediatric group (0.04%) and six in the adult group (0.26%).
Pediatri c group. Th e only seve re co mplication among the children occ urred in a 42-month-old boy, who underwent both a blood tran sfu sion and ligation of the external caro tid artery. Following the boy' s tonsill ect omy, we had reco mmended that this patient ' s hospital disch arge be postponed because he had experienced recurr ent hemorrhage follow ing a previous tonsillectom y, but his mother insisted that he be sent home on postope rati ve day 6. Within hours afte r the boy return ed home, he ex perienced sudden bleedin g from his mouth. He was referred to a pedi atric clini c, where a transfusion was administered. Whil e at the clinic, the boy was diagnosed with signs of deep shock, and he was refe rred back to our clinic. We attempted to save his life by performing ligation of the external carotid artery, but becau se the boy had already lost so much blood, he died the next day. Thi s case rep resents the only fatal outcome during our entire study. .l!l 14 r::
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Resu lts
Hemorrhage rates according to age. The adult group had a sig nificantly higher rate of post-tonsillectom y hemorrhage that required treatment than did the pedi atric gro up (3.9 vs 1.6%; p<O.OOI ). Pediatri c group. Of the 2,567 children, treatment of hem orrh age from the tonsillar fossae was neces sary for 41 patien ts (1.6%)-20 boys and 21 girls. The youngest was 2 years of age and the oldest 14.9 year s (mean: 8.7 ; medi an: 9; SD : ±4.0). Amon g these 41 patients were 23 of the 735 (3.1%) who underw ent tonsillectomy alone and 18 of the 1,832 (0.98%) who underwent adenotonsillectomy . Among the latter gro up, hem orrhag e occurred from the tonsill ar fossae in 10 patient s and at the adenoidectomy site in eight.
Adult group. Of the 2,28 1 adults, 88 (3.9%) requ ired treatment under ge neral anesthes ia for hemorrhage fro m the tonsill ar fossae-58 men and 30 wo men. The youngest patient was 16 years old and the oldes t was 86 (mea n: 33.7; med ian: 29; SD : ± 16.8). Postoperati ve hemorrhage occ urred in 84 of the 2,105 patient s (4.0%) who underwent tonsillectomy alone and in four of the 176 patient s (2.3%) who underwent adenotonsillectomy.
Rates according to procedure. Postoperative hem orrhage was more common amo ng those patient s who underw ent ton sillectomy alone than in those who underwent adenotonsillectomy.
Adenotons illectoniy. A tota l of 2,008 patients underwent adenotonsillectomy-I,832 chi ldren and 176 adults. Hemorrhage from the tonsill ar f os sa e occurr ed in 16 (0.87%) and six (3.4%) patient s, respecti vely (figure 2). Sixteen of the 22 were prim ary bleeds. The latest onset of bleeding was obse rved 6 days followi ng surge ry.
Tonsillectomy alone. T on sillect omy alo ne was performed for treatment of recurrent episodes of ton silliti s on 2 ,8 40 patients-735 children a nd 2 , I 05 adults. Hemorrhage occurred in 23 (3.1%) and 84 (4.0%) patients, re- Adult group . Transfusion was required for three of the 2,281 adults (0.13%). Two of these patients (one who had undergone an adenotonsillectomy and one who had undergone a tonsillectomy plus a uvulopalatoplasty) were transfused on the day of surgery. The other patient received a transfusion after he had experienced unusual bleeding on postoperative days 12 and 18.
Arteria l ligation was performed on three adults (0.13 %) as a result of massive blood loss-a 55-year-old man on the day of surgery after two attempts to stop the bleeding by intraoral suture ligation had failed ; a 22-year-old woman 5 days follow ing surgery; and a 19-year-old man 5 days postoperatively who had experienced continuous bleeding following his surgery.
Discussion
In genera l, post-tonsillectomy hemorrhage occurs in fewer than 10% of cases .' Most of these bleeds are primary. Secondary bleeds can occur at any time during the first 2 postoperative week s.'
Indications for surgery appear to be associated with age. The percentage of adenotonsillectomies that are being performed to treat upper airway obstruction and sleep apnea caused by adenotonsillar hyperp lasia has increa sed significantly during the past 15 years.'>' It is unclear whether this change is attributable to an increase in obstructive airway problems, an increase in diagnosis, or an increase in the number of childre n with adenotonsillar hyperplasi a. In adults , the primary indication for surgery remains infection.
The import ance of being able to provide patients/parents with precise information regarding the expected postoperative course is obvious. Beca use indications for surgery and the risks of postoperative comp lications appear to change depending on the patient's age, the use of a common system of age classification would be helpful. In Germany and some othe r coun tries, childhood legally ends and adulthood begins on the 15th birthday.' Therefore, we used this cutoff point in conducting our study.
Accord ing to our results, chron ic or rec urrent infection likely plays a role in the incide nce of postoperative hemorrhage. We base this assertio n on the facts that (1) bleeding was more common in the adult group and (2) 92.3% of the adult group underwent tonsillectomy alone for treatment of infection (compared with only 28.6 % of the pediatric group). Moreover, the rate of hemorrhage was higherin adults who underwent tonsillectomy alone than in those who underwent adenotonsillectomy (4.0 and 2.3 %, respectively). Likewise, the chi ldren who underwent tons illectomy alone for infection had a higher rate of bleeding than did those who underwent adenotonsillectomy for hyperp lasia (3.1 and 0.98%, respectively).
Studies ofchildren. Previous studies of tonsillectomy in patients younger than 15 years of age have addressed the issue of the safety of postoperative outp atient management. Lee reviewed 3,240 patients younger than 14 years and found that 0.6% had to return to the operating room for treatment of hemorrhage." The mean length of readmiss ion stay was 7 days. All cases of primary bleeding in this study occurred within the first 3 hours . Episodes of secondary hemorrhage were recorded, but no treatment under general anesthesia was necessary for any of these patie nts. Lee concl uded that outpatient tonsillectomy is a safe procedure provided that care is taken to ensure that patients meet proper selection criteria-for examp le, an absence of systemic disease, a positive parental attitude, T he following treatment-related adve rse events were each reported in a sing le SUbject: de rmatitis, ecze ma , erythema tous rash, follicular rash , rash, hypoaesthesia , tinnitus, dyspepsia, ho t flushes. flushing, and otorrhagia.
Subjects with Otitis Extern a
The following trea tment-related adve rse events occu rred in 1% or more of the subjec ts with intact tympan ic membranes.
Sub jects with Acu te Otitis Media with Tym panostomy Tubes and Subjects with Chronic

Suppurative Otitis Media with Perforated Tympanic Membranes
T he following treat me nt-re lated adverse events occ urred in 1% or more of the subjects w ith non-intact tympanic membranes. Nu rsing Mot he rs : In nursing wome n, a single 200 mg oral dose resulted in concentrations of ofloxacin inmilk whichweresimilar to those found inplasma. It is not known w hethe~o fl o xaclĩ sexcretedin human milk fol lowing topical oticadministration. Because of thepotential forsenous adversereactions from ofloxacin in nursing infants, a decision should be made whether to discont inue nursing or to disco ntinue the drug, taking into account the importance of the drug to the mothe r.
Pedi atr ic Use: No changes in hea ring function occ urred in 30 pediatric subjects treated with olloxacin otic and tested for audiometric parameters. Although safety and efficacy have been demo nstrated in pediatric patients one year and older, safety and effectiveness in infants below the age of one year have not bee n established. Although quinolones, including otloxacin, have been shown to cause arthropathy in immature animals after systemic administration, young growi ng guinea pigs dosed in the middle ear with 0.3% of loxacin otic solution for one mon th showed no syste mic effects, quino lone-induced lesions, erosions of the cartilage in weightbea ring joints, or other signs of arthropathy.
ADVERSE REACTIO NS
In the Phase III registration trials, a total of 885 subjects were treated with ofloxacin otic solution.
Th is included 229 subjects with otitis externa (with intact tympanic membra nes) and 656 subjects with acute otitis media with tympa nostomy tubes or chronic suppurative otitis media with pertorated tympanic membranes. Th e reported treatment-related adve rse events are listed below:
Other treatment-related adve rse reactions reported in subjects with non-intact tympanic membranes included: diarrhea (0.6%) , nausea (0.3%) , vomiting (0.3 %) , dr y mo uth (0.5%), headache (0.3%), vert igo (0.5%), otorrhagia (0.6%), tinnitus (0.3%), fever (0.3%). The following treatment-related adve rse events were eac h repo rted in a single subject: applica tion site reaction , otitis externa, urticaria, abdo minal pain, dysaes thesia , hyperkinesia, halitosis, infiamrnation, pain , insomni a, coug hing, pharyngitis, rhinitis, sinusi tis, and tachycardia. DOSAGE AND ADM INISTRATION Otitis Ext ern a: The recom mended dosage regimen for the treat ment of otitis extern a is: For pediatric patients (from 1 to 12 years old): Five drops (0.25 mL , 0.75 mg otloxacin) instilled into the affected ear tw ice daily for ten days. For patients 12 years and older: Ten drops (0.5 mL , 1.5 mg ofloxacin) instilled into the atlecte d ear twice dai ly for ten days. T he solution shou ld be wa rmed by holding the bottle in th e hand for one or two min utes to avoid dizziness which may result from the instillation of a cold solution. The patient should lie with the affected ea r upward, and then the drops sho uld be instilled. This position sho uld be maintained for five minutes to facilitate penetration of the drops into the ear canal. Repeat, if necessary, for the opposite ear. Ac ut e Otitis Medi a in pe d iatric patients with tympano stomy tubes : T he recom me nded dosage regimen for the treatment of acute otitis media in pediatric patients (from one to 12 years old) with tymp anostomy tubes is: Five drops (0.25 mL, 0.75 mg ofloxac in) instilled into the affec ted ear twice daily for ten days . The solution should be warmed by holding the bottle in the hand for one or two minutes to avoid dizziness which may result from the instillation of a cold solution.The patient should lie with the affected ear upward, and then the drops should be instilled.T he tragus should then be pumped 4 times by pushing inward to facilitate penet ration of the drops into the midd le ea r. This position should be maintained for five minut es. Repeat, if nece ssary, for the oppos ite ea r. Chronic Suppurati ve Ot it is Medi a w ith perfo rat ed ty mpanic m emb ran es: The recommended dosage regimen for the treatment of chro nic suppurative otitis media with perforated tympa nic membra nes in pa tien ts 12 years or olde r is: Ten drops (0.5 mL, 1.5 mg ofloxac in) instilled into the affec te d ea r tw ice da ily for fourtee n days. The solution should be wa rmed by holding the bottle in the hand for one or two minutes to avoid dizziness which may result from the instillation of a cold solution. Young grow ing guinea pigs dosed in the middle ear with 0.3% of loxac in otic sol ution showed no systemic effects, lesions or erosio ns of the cartilage in we ight-bea ring joints, or other signs of arthropathy. No drug-related structura l or functional changes of the coc hlea and no lesions in the oss icles were noted in the guinea pig following otic admin istratio n of 0.3% olloxacin for one mon th.
No signs of local irritation we re found whe n 0.3% otloxacin was app lied topically in the rabbit eye. Otloxaci n was also show n to lack der mal sensit izing po tent ial in the gu inea pig max imization study. Inform at ion for Pati ents: Avoid contaminating the applicator tip with material from the fingers or other sources . T his preca utio n is necessar y if the ste rility of the drops is to be preser ved.
Syste mic qulnolones, including ofloxacin, have been associated with hypersensitivity reactions, even following a sing le dose . Discontinue use imm ediately and contac t your phys ician at the first sign of a rash or allergic reaction . Otit is Ext erna Prior to administration of FLOXIN@ Otic in patients with otit is externa , the solution should be wa rmed by holding the bottle in the hand for one or two minutes to avoid dizziness whic h may result from the instillation of a cold solution.The patient sho uld lie with the affected ear upwa rd, and th en the drops should be instilled. Th is posi tion shou ld be mai ntained for five minut es to facilitate penetration of the drops into the ear canal. Repeat, if necessary, for the opposite ear (see DOSAGE AN D AD MINISTRATION).
Acu t e Oti tis Media and Chronic Suppurative Ot iti s Med ia
In pediatric patients (from 1 to 12 yea rs old) with acute otitis media with tympanostomy tubes and in patients with chronic suppurative otitis media with perforated tympanic membranes, prior to adminis tration, the solution should be wa rmed by holding the bo ttle in the hand for one or two minutes to avoid dizzi ness which may result from the instillation of a cold solution. The patient should lie with the affected ear upward, and then the drops should be instilled. The tragus should then be pumped 4 times by pushing inward to facilitate penetration of the drops into the middle ear. This posit ion should be maintaine d for five minut es. Repeat, if necessary, for the oppos ite ear (see DOSAGE A ND AD MINISTRATION). Dru g Int eract ions: Spec ific drug interaction studies have not been conducted w ith FLOXIN@ Otic.
Carc ino g en esis, Mutag en esis, Impairm ent of Fertilit y Long-t erm stud ies to determine th e carcinoge nic potential of otloxac in have not been co nducted . Ofloxacin was not mut agenic in the Ames test, the siste r chro matid exc hange assay (Chinese hamster and hum an cell lines), the unscheduled DNA synt hesis (UDS) assay using hum an fibroblasts, the do mi nant lethal assay, or the mouse micro-nucleus assay. Ofloxac in was positive in the rat hepatocyte UDS assay, and in the mouse lymphoma assay. In rats, ofloxac in did not affect male or fem ale repro ductive perform ance at oral doses up to 36 0 mg/kg/day. This would be ove r 1000 tim es the maximum reco mme nded cli nical dose, base d upon body surface area, ass umi ng total abso rption of ofloxacin from the ear of a patient treated with FLOXIN@ Otic tw ice per day. Pr egn ancy Teratogenic effects : Pregnancy Category C. Ofloxaci n has been shown to have an em bryocida l effect in rats at a dose of 8 10 mg/kg/day and in rabbit s at 160 mg/kg/day. Th ese dosages resulted in decreased fetal body weig hts and increased fetal mortality in rats and rabbits, respectively. Minor fetal skele tal variations were reported in rats receiving doses of 810 mglk g/day. Olloxac in has not been shown to be terato genic at doses as high as 810 mglk glday and 160 mg/kg/day when administered to pregnant rats and rabbits, respectively. Ofloxacin has not been shown to have any adve rse effects on the developing emb ryo or fetus at doses relevant to the amo unt of ofloxacin that will be delivered ototopically at the recommended clinical doses. Nonter at o ge ni c Eff ect s : Addit iona l stud ies in the rat demonstrated that doses up to 360 mglkglday during late gestation had no adverse effects on late fetal developme nt, labor, delivery, lactation, neonatal viab ility, or growth of the newborn. There are, however, no adequate and well-controlled studies in pregnant wo men. FLOXIN@ Otic should be used during pregnancy only if the potential benefit justifies th e po tential risk to the fetus.
INCIDENCE OF POST-TONSILLECTOMY HEMORRHAGE IN CHILD REN AND ADULTS:
A STUD Y OF 4,84 8 PATIENTS favorabl e logi stics with regard to distance and tran sport , and a tractable patient. Lannigan et al performed a retro spec tive study of 4,386 children yo unger than 13 yea rs and found that 0.57% of these patients required treatm ent for episodes of primary bleeding, all of whi ch occurred within 6 hour s of surgery. 7 They did not mention the incidenc e of sec ondary hem orrha ge.
Truy et al compared outcomes in 311 patients younger than 15 years who were scheduled for either inpatient or out patient tonsillectomy .' Inpatient surgery was planned for all patients who were in an unhealthy preoperative state, who had sleep apne a syndrome, who se social circumstances precluded outpatient surge ry, and/or whose parents refused outpatient sur ger y. Among the outpatient s, 23.8 % had to be admitted as a result of po stoperative complications; hemorrhages (most of them primary) had to be treated in 1%.
Lee and Sharp conducted a pro spective que stionnaire study of children younger than 14 years to ascertain the complication rat e (exclud ing primary hemorrhage) during the first 5 da ys postoper ativ ely." Th ey found that hem orrhage was observed in 8.9% of these childre n, but none requ ired surgical treatm ent. Of note is the fact that onl y 291 of the 419 qu esti onn aires (69. 5 %) were suitable for analys is.
Gabalski et al pro specti vely evaluated the incidence of complications during the firs t postoperati ve week in 534 children younger than 15 years who had und ergone outpatient ton sillectomy. 9 They found that bleeding occurred in only two patients (0.37 %); both exper ienced primary hemorrhage and neither required treatment. These dat a wer e collected during an anonymous survey of surgeons who participated in the study voluntarily.
Rakover et al retrospectivel y evaluated risk factors for postoperative complications in 363 children younger than 15 ye ars.10 Eighteen patients (5.0%) experienced a total of 21 hemorrhages-l 4 primary and seve n sec ondary. Surgica l treatment was necessary for only five of the primary bleeds and four of the seco ndary bleed s. Rako ver et al concluded that epi sodes of bleeding th at occur in the recovery room were a significa nt risk factor for complication s. Th e postop erati ve co mplication rate wa s not associa ted with age, indication for surge ry, meth od ofsurge ry, or intraop erati ve complications.
Studies of both children and adults. Kri sten sen and
T veteras published a retrospecti ve analys is of 1,150 patient s between 2 and 71 yea rs of age. ' J They repo rted that 32 ton sillectomies (2.8%) were co mplica ted by hem orrhage-18 primary and 14 secondary . Male patients between 13 and 24 years old were at significant risk. Hemorrhage was associated with previ ou s peritonsillar abscess but not wit h the indication for surgery (e.g ., tonsilliti s, current abscess, or gross hypertrophy).
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Sch roeder conducted a ret rospective study of 756 ton sill ectom y patients age d 2 to 83 years, including an unknown number who had periton sill ar abscess or unil ateral tonsill ar enlargement that sugges ted a neoplasm ." He found that onl y seve n patients (0.93 %; six of them fem ale ) ex perience d postoperati ve hemorrhage that required treatment.
Schmidt et al evaluated the ass ociation between hemorrhage and the method of hem ostasis in 2,096 patients between the age s of3 and 83 years (mean: 22 .5), including tho se with malignant diseases, sleep apnea syndrome, infectious mo nonucleosi s, and peritonsillar abscess. 13They determined that the overall incidence of postoperative hemorrhage was 5.4 %. Primary hemorrhage occurred more oft en when hemostasis wa s achieved by suture ligation than by electrocauter y. Schmidt et al reported th at an age gre ater than 10 years was a risk factor for bleeding; children younger than 10 years had a threefold lower incidence.
Study of adults. Moralee and Murray conducted a
ret rospective study of 2, 157 patients older than 16 ye ars who und er went inpatient tonsill ectomy.v'They found that bleeding occurred in only 42 patients ( 1.9%); 95 % of these hemorrhages occ urre d within 6.8 hour s. Moralee and Mu rra y con clud ed that serious primary hemo rrh age is unc ommon . When it does occ ur, the authors wer e 95 % co nfide nt that the late st onset of bleeding would occur in the range of 5.2 to 8.4 hours postoperativ ely.
Comparisons with other studies. Comparison of our results with those of other researchers is hampered because some reporting criteria were different and because relev ant information wa s not always included in other rep ort s. For example, Lee' s study incl uded patie nts who had been carefully selected, which wa s not the case in our study." Lee and Sharp did not inc lude cases of primary hemorrhage in their results." Kristensen and T veteras!' and Schroeder" did not report the mean age of their patient s, and Schroeder did not indicate the length of foll ow-up. Schmidt et al based their findings on different meth ods of hemosta sis." Th ey also concluded th at patient s yo unge r than 10 years had a low risk of hemorrhage , but they did not relate thi s finding to the particular indi cati on for surge ry." Moralee and Murray did not definitively ide ntify the age di stribution of their patients, their indi cations for surgery, or the nature of their follo w-Up.14 Fin all y, only Schmidt et al took into account the experienc e of the surgeons, so me thing we did not do ."
Oth er authors have rep orted findings that are not in ag ree me nt with our s.5-7.JO-12.14 Some ha ve reported substantially lower rate s of hemorrhage than we did , but we believe the reason for this might be that their studies were smaller th an our s. For example, the rate of bleeding among adults reported by Moralee and Murray (1.9 %) is in sharp contrast to our findings (3.9%).14 Also in contrast to our findings were tho se of Schr oeder ,12 wh o found that most patient s with postoperative hem orrh age were female, and Kristensen and T veteras,I I who fo und th at girls yo unge r than 12 years were at particul ar risk fo r bleed ing. On the other hand , our findi ngs with respect to the rate of hem orrh age in adults was co mpara ble to those of some other studie s.!':" :!"
Because of its retrospective natur e, our study had some limi tation s. For example, we co uld not analyze variabl es of interest such as the len gth of operating tim e, the amou nt of blood loss, patient s' body mas s index , or the precise number of episodes of ton sillitis pri or to surgery because these data were not ava ilable to us. Another dr awb ack is that there was a grea t imbalance in the typ es of surge ry performed in the two age gro ups, which might have made our findin gs susceptible to statistical bias. Th erefore, a prospecti ve study wo uld be most help ful in determin ing whether the risk fact ors we ident ified for hem or rhage (male sex, age~15 yr, an d a history of chronic or recurrent to nsillitis) are valid.
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